Schreiner MediPharm’s trade fair presentation at Pharmapack 2019 in Paris will be fully focused on smart packaging solutions. On February 6 and 7, in Hall 7.2, Booth B32, the specialist for innovative labels and marking solutions with value-added benefits will showcase its latest product developme…
For UV and light protection of particularly sensitive medicines such as biopharmaceuticals, biosimilars, blood products, vaccines and vitamin preparations, Schreiner MediPharm developed three novel labels at various safety levels. They reliably protect liquid substances in transparent glass containe…
A novel dosing syringe label by Schreiner MediPharm supports reliable and exact dosing of a medicine for children as part of a clinical trial. The specialty label was developed for the syringe system made by Raumedic. It serves as a visual barrier, protecting the adjustment button and prevents healt…
The EU Falsified Medicines Directive (FMD) requires pharmaceutical manufacturers to serialize their products and to provide secondary product packaging with an anti-tampering device. Primary containers or devices such as pens and autoinjectors for self-medication, however, are not included in these…
The Europe-wide Falsified Medicines Directive 2011/62/EU coming into force in February 2019 requires all pharmaceutical manufacturers to mark their prescription medicine packaging with a serial number and an additional tamper protection device. Schreiner MediPharm’s multifunctional Covert-Hologram…
Schreiner MediPharm in collaboration with tube manufacturer Neopac and machine producer Harro Höfliger developed an innovative label for a pharmaceutical tube. The special marking label encloses the tube like a pocket, offers ample space for information and can be automatically dispensed on packagi…
Several entries submitted by the Schreiner Group high-tech company convinced the FINAT judging panel this year: The Schreiner MediPharm and Schreiner ProTech business units each received two awards for their developments for the pharmaceutical and engineering-based industries respectively. The accol…
For a multinational pharmaceutical corporation, Schreiner MediPharm developed a smart blister pack for digital patient compliance monitoring to enhance medication adherence by clinical trial participants. Schreiner MediPharm implemented the smart packaging solution together with the Dutch technology…
International pharmaceutical corporation Pfizer opted for Schreiner MediPharm’s Needle-Trap needle protection label to equip the syringes for its epoetin biosimilar. This makes it the first medication for the treatment of anemia to be launched on the market with Needle-Trap–initially in Germany…
The countdown is on: On February 9, 2019, EU Directive 2011/62/EU will come into effect. It aims to stop illegal trade in falsified medicines. From then onwards, pharmaceutical manufacturers have to provide secondary packaging of all medicines placed on the market with an individual serial number as…
Stay up to date and subscribe to our monthly eMail-NEWSLETTER and our NEWSFLASH and NEWSEXTRA. Get additional information about what is happening in the world of cleanrooms with our printed YEARBOOK. And find out who the cleanroom EXPERTS are with our directory.
